Juno Therapeutics, which spun out of Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children’s Research Institute just three years ago, today issued financial ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Nat Levy on Aug 4, 2016 at 3:44 pm ...

SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today reported financial ...

The Juno ASH Investor and Analyst Event and webcast will be held Monday, December 5, 2016 at 8:30 p.m. Pacific Time. The webcast can be accessed live on the Investor Relations page of Juno’s website, ...

After reporting that it has halted trials of its most advanced cancer drug,shares in Juno Therapeutics (NASDAQ: JUNO) lost 57.1% of their value in 2016, according toS&P Global Market Intelligence.

The biotech's stock sank after the company halted its leading drug program. JCAR015 attacks cancer in an entirely novel way. A chimeric antigen receptor T-cell, or CAR-T, therapy, JCAR015 reengineers ...

In a major blow to a new approach to treating cancer, two patients taking an experimental therapy from Juno Therapeutics have died following severe brain swelling, the company said Wednesday. It’s the ...

After a torrid year that has seen multiple deaths in testing, FDA- and self-imposed study halts and its shares tanking, Juno last night held up to the light its new great hope: JCAR017 Juno said that ...

The JunoCam camera aboard NASA's Juno mission is operational and sending down data after the spacecraft's July 4 arrival at Jupiter. Juno's visible-light camera was turned on six days after Juno fired ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Skyworks Solutions, Inc. (NASD: SWKS), where a total of 11,914 contracts have traded so far ...